Page last updated: 2024-11-02

pamidronate and Adult Rickets

pamidronate has been researched along with Adult Rickets in 8 studies

Research Excerpts

ExcerptRelevanceReference
"Inhibition of skeletal mineralisation is a well-recognized complication of disodium etidronate therapy that was identified in the earliest studies of its use in osteoporosis and Paget's disease."3.70Gross vertebral collapse associated with long-term disodium etidronate treatment for pelvic Paget's disease. ( MacGowan, JR; Morris, VH; Pringle, J; Stamp, TC, 2000)
"Pamidronate treatment was associated with development of adynamic bone histology."2.71Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate. ( Bognar, I; Burris, L; Coco, M; Durkin, P; Faugere, MC; Figueroa, K; Glicklich, D; Greenstein, S; Malluche, H; McDonough, P; Schechner, R; Tellis, V; Wang, G, 2003)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (50.00)18.2507
2000's3 (37.50)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Florez, H1
Mandelikova, S1
Filella, X1
Monegal, A1
GuaƱabens, N1
Peris, P1
Rosen, CJ1
Brown, S1
Coco, M1
Glicklich, D1
Faugere, MC1
Burris, L1
Bognar, I1
Durkin, P1
Tellis, V1
Greenstein, S1
Schechner, R1
Figueroa, K1
McDonough, P1
Wang, G1
Malluche, H1
Solomon, CG1
Dluhy, RG1
Adamson, BB2
Gallacher, SJ2
Byars, J2
Ralston, SH2
Boyle, IT2
Boyce, BF2
Reid, IR1
Cundy, T1
Ibbertson, HK1
King, AR1
MacGowan, JR1
Pringle, J1
Morris, VH1
Stamp, TC1

Trials

1 trial available for pamidronate and Adult Rickets

ArticleYear
Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate.
    Journal of the American Society of Nephrology : JASN, 2003, Volume: 14, Issue:10

    Topics: Adult; Anti-Inflammatory Agents; Biopsy; Bone Density; Diphosphonates; Female; Hormones; Humans; Imm

2003

Other Studies

7 other studies available for pamidronate and Adult Rickets

ArticleYear
Clinical significance of increased serum levels of FGF-23 in fibrous dysplasia.
    Medicina clinica, 2018, 07-23, Volume: 151, Issue:2

    Topics: Adult; Aged; Alendronate; Biomarkers; Bone Density Conservation Agents; Female; Fibroblast Growth Fa

2018
Severe hypocalcemia after intravenous bisphosphonate therapy in occult vitamin D deficiency.
    The New England journal of medicine, 2003, Apr-10, Volume: 348, Issue:15

    Topics: Diphosphonates; Female; Gastroplasty; Humans; Hypocalcemia; Infusions, Intravenous; Malabsorption Sy

2003
Paraneoplastic endocrine syndromes.
    Current therapy in endocrinology and metabolism, 1994, Volume: 5

    Topics: Acromegaly; Adrenocorticotropic Hormone; Aminoglutethimide; Bromocriptine; Calcitonin; Cushing Syndr

1994
Mineralisation defects with pamidronate therapy for Paget's disease.
    Lancet (London, England), 1993, Dec-11, Volume: 342, Issue:8885

    Topics: Calcification, Physiologic; Diphosphonates; Female; Humans; Male; Osteitis Deformans; Osteomalacia;

1993
Osteomalacia after pamidronate for Paget's disease.
    Lancet (London, England), 1994, Apr-02, Volume: 343, Issue:8901

    Topics: Diphosphonates; Humans; Osteitis Deformans; Osteomalacia; Pamidronate

1994
Mineralisation defects after pamidronate for Paget's disease.
    Lancet (London, England), 1994, May-14, Volume: 343, Issue:8907

    Topics: Calcification, Physiologic; Diphosphonates; Humans; Hyperparathyroidism, Secondary; Osteitis Deforma

1994
Gross vertebral collapse associated with long-term disodium etidronate treatment for pelvic Paget's disease.
    Skeletal radiology, 2000, Volume: 29, Issue:5

    Topics: Aged; Alkaline Phosphatase; Anti-Inflammatory Agents; Arthralgia; Diphosphonates; Etidronic Acid; Fo

2000